Results 171 to 180 of about 8,164,322 (359)

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Electronic data sources for drug utilization research and healthcare decision-making in Mexico. [PDF]

open access: yesBMC Health Serv Res
Santa-Ana-Tellez Y   +7 more
europepmc   +1 more source

Age and Gender Trends in Prescribing and Utilization of Lipid-Lowering Drugs at a Public Hospital in Alkharj City

open access: diamond, 2020
Nehad J. Ahmed   +3 more
openalex   +2 more sources

Comprehensive drug utilization review in neonates: liposomal amphotericin B

open access: yesThe Journal of pharmacy and pharmacology, 2018
Chirlie Silver, Sara E. Rostas
semanticscholar   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Care pathway in patients after myocardial infarction in Denmark - healthcare and drug utilization. [PDF]

open access: yesInt J Cardiol Heart Vasc
Flege MM   +7 more
europepmc   +1 more source

Donor management using a specialized donor care facility is associated with higher organ utilization from drug overdose donors

open access: green, 2020
C. Corbin Frye   +20 more
openalex   +2 more sources

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

open access: yesMolecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy